Our projects

Optimising malaria vaccine booster deliveryThe SMV delivery project is exploring when and how to provide booster doses of malaria vaccine to children in areas with seasonal transmission to...

Accelerating implementation of low-dose primaquine for malaria controlThe IMPRIMA project is working with national stakeholders and communities to ensure the successful introduction of new...

Combining vaccination and drug-based prevention of malariaThe IMVACS project is assessing whether delivering malaria vaccines as part of seasonal malaria chemoprevention campaigns will...

Promoting use of malaria prevention after hospital discharge in childrenThe PDMC Saves Lives project is helping countries identify the best way to introduce a life-saving new approach to...

Disrupting mosquito feeding to prevent malariaThe LASR project is testing whether a newly developed mosquito repellent can reduce the community burden of malaria infections.

Advancing malaria treatments for pregnant womenAdditional Global Health EDCTP3 funding is completing the evaluation of a new antimalarial treatment for pregnant women.

Boosting the use of anti-parasite drugs during pregnancyThe TreatPreg project is assessing whether a mix of anti-parasite drugs can be given together during pregnancy to prevent anaemia and...

Mitigating the risk of antimalarial resistanceThe MARC-SE Africa project is enabling key countries in Africa to track and respond to rising rates of resistance to antimalarial drugs.

Targeting vectors for infection prediction and controlThe IMPACTING project is collecting data on a host of insect vectors that spread infections to help better predict the risk of...

Advancing test-and-treat strategies for vivax malariaThe PvSeroRDT project is exploring whether a new diagnostic test for Plasmodium vivax could underpin a test-and-treat strategy for this...

Standardised tracking of malaria and tuberculosis drug resistance The PANGenS project will introduce standardised approaches for identifying malaria and TB genetic variants associated with...

Boosting malaria vaccine potencyThe MVC-2G project is advancing a second-generation malaria vaccine targeting an additional stage in the malaria parasite life cycle.

Malaria prevention in children after recovery from hospital careThe R21-PD project is exploring whether malaria vaccination benefits children discharged from hospital after treatment for...

Advancing a next-generation malaria vaccineThe PfVIMT project will move an innovative transmission-blocking malaria vaccine a major step towards authorisation.

Advancing ‘triple therapy’ for malariaThe EDCTP2-funded ASAAP study has received additional Global Health EDCTP3 funding to complete its evaluation of a novel ‘triple therapy’ for malaria.

Tackling severe malaria in remote locationsThe SEMA ReACT study will determine whether children with severe malaria can be treated entirely in the community, when transportation to health...

AI detection of parasite infectionsThe MultiplexAI project is developing an easy-to-use add-on for conventional microscopes that deploys artificial intelligence (AI) models to detect...

Monitoring mosquito populations across AfricaThe VectorGrid-Africa project is developing a platform that could eventually provide an intimate picture of disease-transmitting mosquitoes...

Targeting malaria parasites within mosquitoesThe DEFEND project is piloting a highly innovative strategy to disrupt the spread of malaria by infecting mosquitoes with a strain of bacterium...